Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “SUNSHINE LAKE PHARMA CO., LTD.”

102 pharma patents match "SUNSHINE LAKE PHARMA CO., LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 102
Index total 30,257
Page 1 / 5

Quick answer

This filtered view shows 102 pharmaceutical patents matching "SUNSHINE LAKE PHARMA CO., LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

102 results for “SUNSHINE LAKE PHARMA CO., LTD.” · 30,257 patents in full index Clear search

  1. US 12428432

    Thienopyrimidine derivatives having stereo configurations and use thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Sep 30, 2025 · Expires Sep 25, 2045

    granted
  2. US 12428389

    Diarylamide compound and application thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Sep 30, 2025 · Expires Sep 25, 2045

    granted
  3. US 12324812

    Glucopyranosyl derivatives and their uses

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted
  4. US 12312348

    RET inhibitors, pharmaceutical compositions and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted May 27, 2025 · Expires May 22, 2045

    granted
  5. US 12258317

    Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  6. US 12209085

    RET inhibitors, pharmaceutical compositions and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 28, 2025 · Expires Jan 23, 2045

    granted
  7. US 12171761

    Vilazodone inclusion complexes, compositions and preparation thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  8. US 12145974

    Dual-target fusion proteins comprising FGF21 and GLP-1, connected through a Fc portion of an immunoglobulin

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  9. US 12128044

    Fused tricyclic compounds and uses thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Oct 29, 2024 · Expires Oct 24, 2044

    granted
  10. US 11858910

    Pyridinylmethylenepiperidine derivatives and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  11. US 11679143

    FGF21 variant, fusion protein and application thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  12. US 11517569

    Vilazodone inclusion complexes, compositions and preparation thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  13. US 11447498

    Fused tetracyclic compounds and uses thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  14. US 11396495

    Amine compound for inhibiting SSAO/VAP-1 and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jul 26, 2022 · Expires Jul 21, 2042

    granted
  15. US 11285153

    Substituted pyrimidine piperazine compound and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  16. US 11261190

    Dihydropyrimidine compounds and uses thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  17. US 11242335

    Fluorine-substituted indazole compounds and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted
  18. US 11225460

    Pyrrolidineamide derivatives and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted
  19. US 11225477

    Inhibitors of influenza virus replication, application methods and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted
  20. US 11213529

    Salt of substituted urea derivative and use thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted
  21. US 11208418

    Nitrogenous tricyclic compounds and uses thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  22. US 11186602

    Glucopyranosyl derivative and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted
  23. US 11179376

    Salts of pyrazolo[1,5-a]pyridine derivative and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  24. US 11142527

    Dihydropyrimidine compounds and uses thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted